Public Employees Retirement System Of Ohio Eagle Pharmaceuticals, Inc. Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$4.63 - $15.21 $13,890 - $45,630	3,000 New	3,000 $15,000
Q4 2022 Dec 19, 2023	BUY	$24.98 - $39.77 $7,893 - $12,567	316 New	316 $9,000
Q4 2022 Feb 15, 2023	SELL	$24.98 - $39.77 $10,716 - $17,061	-429 Reduced 57.58%	316 $9,000
Q3 2022 Nov 15, 2022	BUY	$26.42 - $47.12 $7,476 - $13,334	283 Added 61.26%	745 $20,000
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $9,159 - $11,399	222 Added 92.5%	462 $21,000
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $10,699 - $12,624	240 New	240 $12,000
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $783,457 - $927,543	-14,423 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$53.25 - $59.98 $362,153 - $407,923	6,801 Added 89.23%	14,423 $816,000
Q2 2019 Aug 12, 2019	SELL	$46.61 - $58.45 $34,398 - $43,136	-738 Reduced 8.83%	7,622 $424,000
Q4 2018 Feb 15, 2019	BUY	$36.72 - $67.73 $247,419 - $456,364	6,738 Added 415.41%	8,360 $337,000
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $108,106 - $136,020	1,622 New	1,622 $112,000
Q2 2018 Aug 22, 2018	SELL	$51.25 - $76.62 $425,785 - $636,558	-8,308 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$52.16 - $66.86 $6,676 - $8,558	128 Added 1.56%	8,308 $438,000
Q4 2017 Feb 08, 2018	BUY	$49.6 - $60.87 $405,728 - $497,916	8,180 New	8,180 $437,000
Q3 2017 Nov 20, 2017	SELL	$46.62 - $60.36 $384,288 - $497,547	-8,243 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	8,243	8,243 $650,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account